How the new Canine Parvovirus Monoclonal Antibody Works

How does our latest product, the Canine Parvovirus Monoclonal Antibody, actually work? It’s the first treatment that targets parvovirus directly. By targeting the virus directly and binding to it, this treatment disables the virus. In the treatment efficacy study, the Canine Parvovirus Monoclonal Antibody was proven effective in decreasing mortality associated with parvovirus infection.
Learn more about Elanco’s Canine Parvovirus Monoclonal Antibody: www.FightParvo.com